Selected research
Industry Growth & Trends
Global Systemic Antifungals Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Systemic Antifungals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Systemic Antifungals market include MSD, Zhuhai Ebang Pharmaceutical, Chiatai Tianqing, Xian-janssen, Novartis, Merck, Livzon Group Livzon Pharmaceutical Factory, Honz Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Systemic Antifungals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Systemic Antifungals market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Systemic Antifungals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Systemic Antifungals.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Systemic Antifungals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Systemic Antifungals Market by Company
MSD
Zhuhai Ebang Pharmaceutical
Chiatai Tianqing
Xian-janssen
Novartis
Merck
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Pfizer
CR Pharma
Haisco Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical
Bayer
Liposome Company
Gilead Sciences
Astellas Pharma
Systemic Antifungals Segment by Type
Injections
Oral
Systemic Antifungals Segment by Application
Clinic
Hospital
Drugstores
Others
Systemic Antifungals Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Systemic Antifungals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Systemic Antifungals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Systemic Antifungals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Systemic Antifungals companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injections
- Oral
Applications
- Clinic
- Hospital
- Drugstores
- Others
Companies covered
- MSD
- Zhuhai Ebang Pharmaceutical
- Chiatai Tianqing
- Xian-janssen
- Novartis
- Merck
- Livzon Group Livzon Pharmaceutical Factory
- Honz Pharmaceutical
- Pfizer
- CR Pharma
- Haisco Pharmaceutical
- Medisan
- Chengdu Brilliant Pharmaceutical
- Bayer
- Liposome Company
- Gilead Sciences
- Astellas Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Systemic Antifungals Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Systemic Antifungals Market Size by Region (2021-2032)
- 1.4.1 Global Systemic Antifungals Market Size by Region (2021-2026)
- 1.4.2 Global Systemic Antifungals Market Size by Region (2027-2032)
- 1.5 Key Regions Systemic Antifungals Market Size (2021-2032)
- 1.5.1 North America Systemic Antifungals Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Systemic Antifungals Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Systemic Antifungals Market Size Growth Rate (2021-2032)
- 1.5.4 South America Systemic Antifungals Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Systemic Antifungals Market Size Growth Rate (2021-2032)
2 Systemic Antifungals Market by Type
- 2.1 Type Introduction
- 2.1.1 Injections
- 2.1.2 Oral
- 2.2 Global Systemic Antifungals Market Size by Type
- 2.2.1 Global Systemic Antifungals Market Size Overview by Type (2021-2032)
- 2.2.2 Global Systemic Antifungals Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Systemic Antifungals Market Size Forecasted by Type (2027-2032)
- 2.3 Global Systemic Antifungals Market Size by Regions
- 2.3.1 North America Systemic Antifungals Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Systemic Antifungals Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Systemic Antifungals Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Systemic Antifungals Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Systemic Antifungals Market Size Breakdown by Type (2021-2026)
3 Systemic Antifungals Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinic
- 3.1.2 Hospital
- 3.1.3 Drugstores
- 3.1.4 Others
- 3.2 Global Systemic Antifungals Market Size by Application
- 3.2.1 Global Systemic Antifungals Market Size Overview by Application (2021-2032)
- 3.2.2 Global Systemic Antifungals Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Systemic Antifungals Market Size Forecasted by Application (2027-2032)
- 3.3 Global Systemic Antifungals Market Size by Regions
- 3.3.1 North America Systemic Antifungals Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Systemic Antifungals Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Systemic Antifungals Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Systemic Antifungals Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Systemic Antifungals Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Systemic Antifungals Industry Trends
- 4.2 Systemic Antifungals Industry Drivers
- 4.3 Systemic Antifungals Industry Opportunities and Challenges
- 4.4 Systemic Antifungals Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Systemic Antifungals Revenue (2021-2026)
- 5.2 Global Systemic Antifungals Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Systemic Antifungals Key Company Headquarters & Area Served
- 5.4 Global Systemic Antifungals Company, Product Type & Application
- 5.5 Global Systemic Antifungals Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Systemic Antifungals Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Systemic Antifungals Players Market Share by Revenue in 2025
- 5.6.3 2025 Systemic Antifungals Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 MSD
- 6.1.1 MSD Company Information
- 6.1.2 MSD Business Overview
- 6.1.3 MSD Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 MSD Systemic Antifungals Product Portfolio
- 6.1.5 MSD Recent Developments
- 6.2 Zhuhai Ebang Pharmaceutical
- 6.2.1 Zhuhai Ebang Pharmaceutical Company Information
- 6.2.2 Zhuhai Ebang Pharmaceutical Business Overview
- 6.2.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Portfolio
- 6.2.5 Zhuhai Ebang Pharmaceutical Recent Developments
- 6.3 Chiatai Tianqing
- 6.3.1 Chiatai Tianqing Company Information
- 6.3.2 Chiatai Tianqing Business Overview
- 6.3.3 Chiatai Tianqing Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Chiatai Tianqing Systemic Antifungals Product Portfolio
- 6.3.5 Chiatai Tianqing Recent Developments
- 6.4 Xian-janssen
- 6.4.1 Xian-janssen Company Information
- 6.4.2 Xian-janssen Business Overview
- 6.4.3 Xian-janssen Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Xian-janssen Systemic Antifungals Product Portfolio
- 6.4.5 Xian-janssen Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Novartis Systemic Antifungals Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Merck Systemic Antifungals Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Livzon Group Livzon Pharmaceutical Factory
- 6.7.1 Livzon Group Livzon Pharmaceutical Factory Company Information
- 6.7.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
- 6.7.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Portfolio
- 6.7.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
- 6.8 Honz Pharmaceutical
- 6.8.1 Honz Pharmaceutical Company Information
- 6.8.2 Honz Pharmaceutical Business Overview
- 6.8.3 Honz Pharmaceutical Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Honz Pharmaceutical Systemic Antifungals Product Portfolio
- 6.8.5 Honz Pharmaceutical Recent Developments
- 6.9 Pfizer
- 6.9.1 Pfizer Company Information
- 6.9.2 Pfizer Business Overview
- 6.9.3 Pfizer Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Pfizer Systemic Antifungals Product Portfolio
- 6.9.5 Pfizer Recent Developments
- 6.10 CR Pharma
- 6.10.1 CR Pharma Company Information
- 6.10.2 CR Pharma Business Overview
- 6.10.3 CR Pharma Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CR Pharma Systemic Antifungals Product Portfolio
- 6.10.5 CR Pharma Recent Developments
- 6.11 Haisco Pharmaceutical
- 6.11.1 Haisco Pharmaceutical Company Information
- 6.11.2 Haisco Pharmaceutical Business Overview
- 6.11.3 Haisco Pharmaceutical Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Haisco Pharmaceutical Systemic Antifungals Product Portfolio
- 6.11.5 Haisco Pharmaceutical Recent Developments
- 6.12 Medisan
- 6.12.1 Medisan Company Information
- 6.12.2 Medisan Business Overview
- 6.12.3 Medisan Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Medisan Systemic Antifungals Product Portfolio
- 6.12.5 Medisan Recent Developments
- 6.13 Chengdu Brilliant Pharmaceutical
- 6.13.1 Chengdu Brilliant Pharmaceutical Company Information
- 6.13.2 Chengdu Brilliant Pharmaceutical Business Overview
- 6.13.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Portfolio
- 6.13.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 6.14 Bayer
- 6.14.1 Bayer Company Information
- 6.14.2 Bayer Business Overview
- 6.14.3 Bayer Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Bayer Systemic Antifungals Product Portfolio
- 6.14.5 Bayer Recent Developments
- 6.15 Liposome Company
- 6.15.1 Liposome Company Company Information
- 6.15.2 Liposome Company Business Overview
- 6.15.3 Liposome Company Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Liposome Company Systemic Antifungals Product Portfolio
- 6.15.5 Liposome Company Recent Developments
- 6.16 Gilead Sciences
- 6.16.1 Gilead Sciences Company Information
- 6.16.2 Gilead Sciences Business Overview
- 6.16.3 Gilead Sciences Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Gilead Sciences Systemic Antifungals Product Portfolio
- 6.16.5 Gilead Sciences Recent Developments
- 6.17 Astellas Pharma
- 6.17.1 Astellas Pharma Company Information
- 6.17.2 Astellas Pharma Business Overview
- 6.17.3 Astellas Pharma Systemic Antifungals Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Astellas Pharma Systemic Antifungals Product Portfolio
- 6.17.5 Astellas Pharma Recent Developments
7 North America
- 7.1 North America Systemic Antifungals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Systemic Antifungals Market Size by Country (2021-2026)
- 7.3 North America Systemic Antifungals Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Systemic Antifungals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Systemic Antifungals Market Size by Country (2021-2026)
- 8.3 Europe Systemic Antifungals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Systemic Antifungals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Systemic Antifungals Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Systemic Antifungals Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Systemic Antifungals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Systemic Antifungals Market Size by Country (2021-2026)
- 10.3 South America Systemic Antifungals Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Systemic Antifungals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Systemic Antifungals Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Systemic Antifungals Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst